<DOC>
	<DOCNO>NCT01477879</DOCNO>
	<brief_summary>This study compare efficacy versabase gel 20 % sarracenia purpurea versus placebo apply every 3-4 hour herpes lesion .</brief_summary>
	<brief_title>Hsv 1 2 Gowey Protocol Versus Placebo</brief_title>
	<detailed_description>Patients screen hsv one two . Patients herpes give 1/8 oz gel . Researcher know active placebo ( placebo actually versabase gel ) . Patent applies gel lesion every 3-4 hour . Returns clinic day 3 , 5 , 14 evaluation . Up 50 patient may enrol .</detailed_description>
	<criteria>Hsv 1 &amp; 2 No active lesion</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2011</verification_date>
</DOC>